DE2552266A1 - (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine - Google Patents
(1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamineInfo
- Publication number
- DE2552266A1 DE2552266A1 DE19752552266 DE2552266A DE2552266A1 DE 2552266 A1 DE2552266 A1 DE 2552266A1 DE 19752552266 DE19752552266 DE 19752552266 DE 2552266 A DE2552266 A DE 2552266A DE 2552266 A1 DE2552266 A1 DE 2552266A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- optionally
- compounds
- trimethyl
- inert solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Die Erfindung betrifft neue Cyclohexylamin-Derivate derThe invention relates to new cyclohexylamine derivatives
allgemeinen Formel I, Verfahren zu ihrer Herstellung und ihre pharmazeutische Anwendhung. general formula I, process for their preparation and their pharmaceutical application.
in der R einen Phenyl- oder naphthylrest bedeutet, der gegebenenfalls durch Halogene, Trifluoromethylgruppe, gerade oder verzweigte Alkyl- und/oder Alkõxy- und/oder Thioalkylgruppen mit 1 bis 4 Kohlenstoffatomen, Alkenylreste mit 3 bis 6 Kohlenstoffatomen, Nitro-, Amino-, Hydroxy-, Nitril-, Rhodan-, Acyl- mit 2 bin 4 Kohlenstoffatomen, Aryl-, Aralkyl-, Aralkyloxygruppen und/oder eine Ureidogruppe, gegebenenfalls substituiert ist, X für Sauerstoff oder Schwefel, R1 für Wasserstoff oder eine Niederalkylgruppe mit 1 bis 4 Lohlenstoffatomen steht.in which R denotes a phenyl or naphthyl radical, which optionally by halogens, trifluoromethyl groups, straight or branched alkyl and / or alkoxy and / or thioalkyl groups with 1 to 4 carbon atoms, alkenyl groups with 3 to 6 carbon atoms, nitro, amino, hydroxy, nitrile, rhodan, acyl with 2 am 4 carbon atoms, aryl, aralkyl, aralkyloxy groups and / or one ureido group, is optionally substituted, X for oxygen or sulfur, R1 for hydrogen or a lower alkyl group having 1 to 4 carbon atoms.
Die erfindungsgemäßen Produkte der Formel I können nach folgenden au sich bekannten Verfahren erhalten werden, wobei R, R1 und X in den nachfolgenden Formeln die gleiche Bedeutung haben wie in Formel I.The products of the formula I according to the invention can be according to the following known processes can be obtained, where R, R1 and X in the following Formulas have the same meaning as in formula I.
1. Durch Umsetzung den Cyclododecylamins der allgemeinen Formel II mit cinem Arylglycidae-tller der allgemeinen Formel III bei erhöhter Temperatur, gegebenenfalls in Anwesenheit eines inerten Lösungsmittels, oder mit einer Verbindung der allgemeinen Formel IV, worin lial für Chlor, Brom oder Jod steht, bei erhöhter Temperatur, gegebenenfalls in Anwesenheit eines inerten Lösungsmittels und/oder eines Säurefängers.1. By reacting the cyclododecylamine of the general formula II with an Arylglycidae-tller of the general formula III at elevated temperature, optionally in the presence of an inert solvent, or with a compound of the general formula IV, where lial stands for chlorine, bromine or iodine, at an elevated temperature, optionally in the presence of an inert solvent and / or an acid scavenger.
2. Durch Umsetzung des 3,3,5-Trimethyl-cyclohexyl-amino-2,3-oxydopropan der allgemeinen Formel V oder eines 3,3,5-Trimethyl-cyclohexyl-amino-2-hydroxy prolzan-llalogenid-(3) der allgemeinen Formel VI, worin Hal ein Halogenatom, wie vorzugsweise Chlor oder Brom ist, mit einem Phenol oder Naphthol der allgemeinen Formel VII bei erhöhter Temperatur, gegebenenfalls in Anwesenheit eines inerten Lösungsmittels tu1d/oder in einem alkalischen Ililieu.2. By reacting the 3,3,5-trimethyl-cyclohexyl-amino-2,3-oxydopropane of the general formula V or a 3,3,5-trimethyl-cyclohexyl-amino-2-hydroxy prolzan-llalogenid- (3) of the general formula VI, wherein Hal is a halogen atom, such as preferably chlorine or bromine, with a phenol or naphthol of the general formula VII at elevated temperature, optionally in the presence of an inert solvent tu1d / or in an alkaline environment.
3. Durch Umsetzung einer Verbindung der allgemeinen Formel VIII mit einem 3,3,5-Trimethyl-cyclohexyl-halogenid, vorzugsweise dem Chlorid, bei erhöhter Temperatur, gegebenenfalls in Anwesenheit eines inerten Lösungsmittels und/oder eines Säurefängers, wobei R ein Phenol oder Naphthol sein kann.3. By reacting a compound of the general formula VIII with a 3,3,5-trimethyl-cyclohexyl halide, preferably the chloride, at elevated temperature, optionally in the presence of an inert solvent and / or an acid scavenger, where R can be a phenol or naphthol.
4. Durch Reduktion einer Verbindung der allgemeinen Formel IX zum entsprechenden Alkohol durch z. B. Hydrierung in Anwesenheit eines geeigneten Katalysators, wie z. B. Platinoxyd, gegebenenfalls in Gegenwert eines inerten Lösungsmittels, wobei R ein Pehnol oder Naphthol sein kann.4. By reducing a compound of the general formula IX to the corresponding alcohol by z. B. hydrogenation in the presence of a suitable catalyst, such as. B. platinum oxide, optionally in the equivalent of an inert solvent, where R can be a phenol or naphthol.
5. Durch Hydrolyse von Oxazolidonen der allgemeinen Formel X und gegebenenfalls Umsetzung des Reaktionsproduktes mit einem Alkylierungsmittels, wie z. B. Methylhalogenid, Diaethylsulfat oder Ameisensäure (nach Eschweiler-Clark), gegebenenfalls bei erhöhter Temperatur und in Anwesenheit eines inerten Lösungsmittels, R kann ein Phenol oder Naphthol sein.5. By hydrolysis of oxazolidones of the general formula X and optionally reacting the reaction product with an alkylating agent, such as. B. methyl halide, diethyl sulfate or formic acid (according to Eschweiler-Clark), optionally at elevated temperature and in the presence of an inert solvent, R can be a phenol or naphthol.
Die Umsetzung der Reaktionspartner erfolgt weitgehendet in äquinolaren Vorhältnissen.The reaction partners are largely converted into equinolar amounts Conditions.
Aus den Basen können Salze mit physiologisch vorträglichen anorganischen oder organischen Säuren hergestellt werden.The bases can be converted into salts with physiologically acceptable inorganic salts or organic acids.
Als Beispiele für physiologisch unbedenkliche anorganische und organische Säuren, die zur Salzbildung geeignet sind, seien genannt, Chlorwasserstoff-, Bromwaserstoff-, Jodwasserstoff-, Schwefel,- Salopeter-, Phosphor-, Essig-, Glukon-, Milch-, Malon-, Malcin-, Bernstein-, Fumar-, Wein-, Zitronen-, Benzoe-, ß-Oxy-naphthol-, Embon- oder Theophyllinossigsäure.As examples of physiologically harmless inorganic and organic Acids that are suitable for salt formation may be mentioned, hydrogen chloride, hydrogen bromide, Hydrogen iodide, sulfur, salopeter, phosphorus, vinegar, glucon, milk, malon, Malcin, amber, fumar, wine, lemon, benzoin, ß-oxynaphthol, embon or theophyllinosetic acid.
Die erfindungsgemäßen Verbindungen treten entsprechend dem Asymetriezentrum am Kohlenstoffatom 2 der Seitenkette in optisch aktiven Isomeren auf, die nach bekannten Verfahren aufgetrennt werden können.The compounds according to the invention occur according to the center of asymmetry on carbon atom 2 of the side chain in optically active isomers, which according to known Procedures can be separated.
Die erfindungsgemäßen Cyclohexylamin-Derivate und ihre physiologisch unbedeklichen Salze besitzen wertvolle therapeutische Eigenschaften.The cyclohexylamine derivatives according to the invention and their physiological harmless salts have valuable therapeutic properties.
Bei spiel: 19,7 g 1-(3-Chlor-5-methyl-phenoxy)-2,3-epoxypropan werden mit 14,1 g 3,3,5-Trimethyl-cyclohexylamin in 200 ml abs. Aethanol ca. 8 Stunden am Rückfluß erhitzt. Nach Abdestillieren des Alkohols im Vakuum wird der Rückstand in Aether gelöst. In diese Aether-Lösung leitet man unter Eiskühlung Chlorwasserstoff bis zur Sättigung cin. Der Niederschlag wird abgesaugt und aus Benzol umkristallisiert.For example: 19.7 g of 1- (3-chloro-5-methyl-phenoxy) -2,3-epoxypropane are used with 14.1 g of 3,3,5-trimethyl-cyclohexylamine in 200 ml of abs. Ethanol approx. 8 hours heated to reflux. After the alcohol has been distilled off in vacuo, the residue becomes dissolved in ether. Hydrogen chloride is passed into this ethereal solution while cooling with ice until saturation cin. The precipitate is filtered off with suction and recrystallized from benzene.
Fp. 180 - 182° Analyse: C19H30ClNO2 x HCl Mol. -Gew. 376,38 ber. gef.Mp. 180-182 ° Analysis: C19H30ClNO2 x HCl mol. Wt. 376.38 calc.
C 60,63% 60,78% H 8,3% 8,33% H 3,72% 3,69%
Weiter
wurden folgende Substanzen hergestellt:
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752552266 DE2552266A1 (en) | 1975-11-21 | 1975-11-21 | (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752552266 DE2552266A1 (en) | 1975-11-21 | 1975-11-21 | (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2552266A1 true DE2552266A1 (en) | 1977-05-26 |
Family
ID=5962298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19752552266 Pending DE2552266A1 (en) | 1975-11-21 | 1975-11-21 | (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE2552266A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2405932A1 (en) * | 1977-10-11 | 1979-05-11 | Bristol Myers Co | NEW ALKYLTHIOPHENOXYPROPANOLAMINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM |
DE2935901A1 (en) * | 1979-09-05 | 1981-04-02 | A. Nattermann & Cie GmbH, 5000 Köln | 1-PHENYLTHIO-3-ALKYLAMINO-2-PROPANOLS AND THEIR ACID ADDITIONAL SALTS, METHODS FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM |
-
1975
- 1975-11-21 DE DE19752552266 patent/DE2552266A1/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2405932A1 (en) * | 1977-10-11 | 1979-05-11 | Bristol Myers Co | NEW ALKYLTHIOPHENOXYPROPANOLAMINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM |
DE2935901A1 (en) * | 1979-09-05 | 1981-04-02 | A. Nattermann & Cie GmbH, 5000 Köln | 1-PHENYLTHIO-3-ALKYLAMINO-2-PROPANOLS AND THEIR ACID ADDITIONAL SALTS, METHODS FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2552266A1 (en) | (1)-Aryloxy or arylthio-(3)-cyclohexylamino-(2)-propanol derivs. - prepd. e.g. by reacting epoxy propane cpds. with (3,3,5)-trimethyl-cyclohexylamine | |
DE1103342B (en) | Process for the preparation of new 1, 2-diphenyl-3, 5-dioxo-1, 2, 4-triazolidine derivatives | |
DE1111208B (en) | Process for the production of cough-relieving, basic substituted diphenylcarbinol esters | |
DE2551141A1 (en) | (1)-Cyclododecylamino'(2)-hydroxy-propane derivs. - selective beta-receptor blockers | |
DE2061864B2 (en) | Acyl derivatives of substituted bis-arylalkylamines | |
DE1258412B (en) | Process for the preparation of 5,5-bis- (p-hydroxyphenyl) -imidazolinonen- (4) and their salts | |
DE1693032B1 (en) | Process for the preparation of 1,2-disubstituted adamantane compounds | |
DE946058C (en) | Process for the preparation of 3-aminoindanes | |
EP0009168A1 (en) | Isopropyl amine derivatives, processes for their preparation and medicaments containing them | |
DE950550C (en) | Process for the preparation of basic substituted phenylcycloalkenylpropanols | |
DE1200825B (en) | Process for the preparation of 3, 5-dioxo-triazolidines | |
DE1518652A1 (en) | Process for the preparation of pharmaceutically active derivatives of 2-aminoindane | |
DE1620128B2 (en) | N-AMINOALKYL-2-PHENOXY-2-PHENYLACETAMIDE, THEIR ACID-ADDITIONAL SALTS AND THE PROCESS FOR THEIR PRODUCTION | |
DE859892C (en) | Process for the preparation of substituted piperidinoacetic acid esters | |
DE1103936B (en) | Process for the preparation of substituted 2,3-diphenyl-propylamines | |
DE1470357C (en) | 1 (3 Dimethylammopropyl) 4 myristoyl amidopiperidine, its acid addition salts and process for their preparation | |
DE1018869B (en) | Process for the preparation of aminoalkyl purine derivatives | |
DE1670543C (en) | Substituted 2 morpholino 4 piperazi no 6 amino s triazine | |
DE2839505A1 (en) | 1-Amino-3-nitro:phenoxy-2-propanol derivs. - with beta-adrenergic blocking and platelet aggregation inhibiting activity | |
DE1133395B (en) | Process for the production of phenylalkylamines with cardiovascular effects | |
AT254850B (en) | Process for the preparation of new secondary amines and their salts | |
DE1018868B (en) | Process for the preparation of phenthiazine derivatives | |
AT201588B (en) | Process for the preparation of new aryloxyacetic acid amides | |
DE1568245C (en) | Process for the preparation of phenyl isopropylamines | |
DE1518633A1 (en) | Process for the preparation of pharmaceutically active derivatives of 2-aminoindane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHN | Withdrawal |